Director, Value & Evidence Programs
Role Overview
Integrated Value & Evidence Strategy (IVES) brings together clinical, comparative, economic, real-world, and patient-centered evidence to inform CG Oncology's clinical development, launch readiness, market access, and lifecycle strategies.
Working across functions, IVES ensures that evidence generation is aligned with key scientific, clinical, and business decisions.
The Director, Value & Evidence Programs will serve as a senior scientific and program execution leader within IVES. Reporting to the Senior Director, IVES, this individual will lead the design, integration, and delivery of assigned evidence programs within the enterprise IVES roadmap, ensuring that evidence investments translate into scientifically credible, decision-relevant outputs supporting clinical development, launch readiness, market access, commercialization, and lifecycle strategy.
The role requires deep expertise in value and evidence generation, together with multidisciplinary breadth across health economics and outcomes research (HEOR), comparative effectiveness, evidence synthesis, real-world evidence (RWE), patient-centered evidence, and payer/HTA evidence.
The successful candidate will combine scientific and methodological judgment with business acumen and strong program leadership to connect evidence generation with the clinical, provider, payer, and business decisions it is intended to support.
Working across Clinical Development, Medical Affairs, Clinical Science, Biostatistics, Market Access, Commercial, Regulatory, and other partners, this individual will independently lead assigned evidence programs from concept through execution, interpretation, dissemination, and application.
The Director will provide scientific leadership to external research partners and collaborators while helping IVES scale an expanding pre-launch and lifecycle evidence portfolio.
Full Job Posting
About CG Oncology, Inc.
Are you ready to make a difference in the world and become part of our patient-centered team that is focused on Attacking Bladder Cancer for a Better Tomorrow? At CG Oncology, we believe that by having exceptionally talented individuals on our team who share our passion and enjoy working together, we can truly achieve our Vision and Mission to benefit patients around the world.
Every day we are making significant advancements across our multiple pipelines and are growing rapidly to meet the needs of our patients who cannot afford to wait to benefit from our novel immunotherapies. Please review this job posting and our Values and if they resonate with you and are what you expect from your organization and team, then we would like to hear from you.
About the role
Integrated Value & Evidence Strategy (IVES) brings together clinical, comparative, economic, real-world, and patient-centered evidence to inform CG Oncology's clinical development, launch readiness, market access, and lifecycle strategies. Working across functions, IVES ensures that evidence generation is aligned with key scientific, clinical, and business decisions.
The Director, Value & Evidence Programs will serve as a senior scientific and program execution leader within IVES. Reporting to the Senior Director, IVES, this individual will lead the design, integration, and delivery of assigned evidence programs within the enterprise IVES roadmap, ensuring that evidence investments translate into scientifically credible, decision-relevant outputs supporting clinical development, launch readiness, market access, commercialization, and lifecycle strategy.
The role requires deep expertise in value and evidence generation, together with multidisciplinary breadth across health economics and outcomes research (HEOR), comparative effectiveness, evidence synthesis, real-world evidence (RWE), patient-centered evidence, and payer/HTA evidence. The successful candidate will combine scientific and methodological judgment with business acumen and strong program leadership to connect evidence generation with the clinical, provider, payer, and business decisions it is intended to support.
Working across Clinical Development, Medical Affairs, Clinical Science, Biostatistics, Market Access, Commercial, Regulatory, and other partners, this individual will independently lead assigned evidence programs from concept through execution, interpretation, dissemination, and application. The Director will provide scientific leadership to external research partners and collaborators while helping IVES scale an expanding pre-launch and lifecycle evidence portfolio.
Essential Functions
Evidence Program Leadership: Independently lead assigned complex value and evidence programs from research question formulation and study design through execution, interpretation, dissemination, and stakeholder application, translating established IVES priorities into actionable research plans, technical specifications, timelines, and deliverables.
Scientific and Methodological Oversight: Lead and provide scientific oversight across health economic modeling, comparative effectiveness and indirect treatment comparisons, systematic literature reviews/evidence synthesis, burden-of-illness and healthcare resource utilization research, and other outcomes research. Integrate RWE/epidemiology and patient-centered evidence as appropriate, critically evaluating study designs, data sources, assumptions, methods, and results.
Cross-Functional Evidence Integration: Partner with Clinical Development, Clinical Science, Biostatistics, Medical Affairs, Market Access, Commercial, Regulatory, and other stakeholders to ensure evidence programs address clinically meaningful questions and support development, launch readiness, reimbursement, and lifecycle decisions.
Value and Evidence Translation: Connect research findings across clinical, comparative, economic, real-world, and patient-centered evidence to the broader IVES value narrative, translating complex results into actionable insights supporting clinical differentiation, provider decision-making, payer/HTA assessments, and other stakeholder needs.
External Research and Scientific Collaboration: Provide day-to-day scientific and technical leadership to external research organizations, data partners, methodologists, and assigned clinical/KOL collaborators, critically challenging research approaches, ensuring scientific quality, and managing partner performance and deliverables.
Scientific Dissemination and Evidence Planning: Drive peer-reviewed publications, congress presentations, and other scientific dissemination activities in collaboration with relevant functions. Monitor emerging evidence, competitive developments, and stakeholder needs to identify evidence gaps and recommend future research opportunities to IVES leadership.
Integrated Program Execution and Resource Management: Drive coordinated execution across multiple evidence workstreams, managing project plans, milestones, dependencies, risks, vendor commitments, budgets, forecasts, and resources. Proactively resolve execution challenges and escalate material scientific, strategic, or investment decisions to IVES leadership.
Functional Representation and Capability Building: Represent IVES in designated cross-functional workstreams and governance forums, contribute to the development of scalable evidence-generation methods, operating standards, and infrastructure, and support mentoring and team development as the function expands.
Qualifications
- Advanced degree (PhD, PharmD, MD, MPH, MS or equivalent) in health economics, outcomes research, epidemiology, public health, health services research, pharmacy, medicine, or a related scientific discipline.
- Approximately 8+ years of relevant experience in biopharmaceutical evidence generation and/or healthcare/life-sciences consulting, with demonstrated progression in scientific and program leadership.
- Demonstrated experience independently leading complex, multidisciplinary evidence programs or consulting engagements from problem definition and research strategy through execution, interpretation, scientific dissemination, and stakeholder application.
- Demonstrated scientific and methodological depth in at least two core value and evidence-generation disciplines, with strong multidisciplinary breadth across several of the following: health economic modeling, comparative effectiveness and indirect treatment comparisons, systematic literature reviews/evidence synthesis, real-world evidence (RWE)/observational research, healthcare resource utilization, burden-of-illness research, patient-centered clinical outcomes assessment (PRO/COA), payer evidence, and/or health technology assessment (HTA). Ability to critically evaluate, integrate, and independently lead research programs spanning multiple evidence domains.
- Ability to critically evaluate comparative clinical evidence, comparator selection, endpoint definitions, heterogeneity, study design, statistical methods, model assumptions, data sources, bias/confounding, uncertainty, and interpretation without needing to personally perform every analysis.
- Demonstrated ability to connect technical evidence to stakeholder and business questions and to translate complex analyses into clear implications and recommendations.
- Demonstrated success leading cross-functional work with partners such as Clinical Development, Medical Affairs, Biostatistics, Market Access, Commercial, or equivalent client stakeholders.
- Experience leading external research organizations, technical vendors, data partners, multidisciplinary consulting teams, and/or scientific collaborators.
- Track record of scientific dissemination through peer-reviewed manuscripts, congress presentations, reimbursement/HTA evidence, or other scientific communications.
- Ability to lead multiple concurrent programs with a high degree of independence in a fast-paced, resource-efficient biotechnology or consulting environment.
Work Authorization for US Applicants: Applicants must be authorized to work for any employer in the U.S. We are unable to sponsor or take over sponsorship of an employment visa at this time.
Please note that CG Oncology does not accept unsolicited information and/or resumes from search firms or agencies for our job postings. Any resumes or client information submitted to our careers page or any employee of CG Oncology by any search firm or agency without an applicable contract in place will become the property of CG Oncology and no fee(s) will be paid.
Total Rewards
CG Oncology offers very competitive and comprehensive Total Rewards, helping to support and reward our global team of high-performing employees focused on developing bladder-saving therapeutics for patients afflicted with bladder cancer.
HIGHLY COMPETITIVE SALARIES
ANNUAL PERFORMANCE/MERIT REVIEWS
ANNUAL PERFORMANCE BONUSES
EQUITYSPECIAL RECOGNITION
Well-Being Benefits
In addition to our Total Rewards, CG Oncology offers a variety of Well-Being Benefits to meet the majority of the needs of our unique and growing workforce. These benefits are designed to support our team to achieve a healthy balance between work and their personal lives to remain refreshed, engaged, and creating an environment where each person can find a deeper meaning and purpose in their work.
Well-Being Benefits eligibility begins the 1st of the month after hire. While a majority of these benefits are for our US-based workforce, we continue to assess comparable levels of benefits for our international team members that are aligned with country-specific regulations and their national programs offered.
FULLY REMOTE WORK ENVIRONMENT
REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off
HOLIDAYS - In 2026 we will observe 14 holidays
RETIREMENT - 401K with 100% company Safe Harbor match up to 4% of base salary
HEALTH (MEDICAL, DENTAL, VISION) - PPO & HDHP - Cigna/Principal
HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
ILLNESS & DISABILITY PROTECTION - Company Paid LTD Coverage + Voluntary Plans
LIFE INSURANCE - Company Paid 2 x base salary + Voluntary Plans
ADDITIONAL EXCLUSIVE BENEFITS - Voluntary Legal, Pet, Plus More
CG Oncology is an Equal Opportunity Employer:
All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. At CG Oncology, we are building a community of intelligent and passionate team members that share our Vision, Mission and Values, and while the biotechnology space can feel limited in BIPOC, non-binary and even female representation, we endeavor to make hiring decisions that will continue to grow and support our team in the direction of maintaining cultural diversity and sustainability.
About CG Oncology, Inc.
A publicly traded clinical biopharmaceutical company developing bladder-sparing immunotherapies for people with bladder cancer.
Visit company websiteJobs and hiring trendsApply for this job in 1 click
Skip the repetitive application forms
Install the Base Career Chrome Extension and autofill job applications across major job boards with your profile.
Trusted by over 500,000 job seekers on Base Career
More from this employer
More jobs at CG Oncology, Inc.
Senior Director, Patient Services & Access Operations
, USA
Director, Employee Communications
, USA
Senior Director, Patient Services & Access Operations
, USA
AVP, CMC Strategy & Portfolio Management
, USA
Manager, Payroll & Equity Accounting
, USA
Director, Peer-to-Peer Marketing
, USA
Senior Director, Field Medical Affairs
, USA
HR Specialist, People Operations & Administra
, USA
